SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001395064-19-000081
Filing Date
2019-11-22
Accepted
2019-11-22 06:19:07
Documents
1
Period of Report
2019-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_157442152990600.html 3  
1 FORM 3 wf-form3_157442152990600.xml 3 6942
  Complete submission text file 0001395064-19-000081.txt   9148
Mailing Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139 6176797000
MILLENNIUM PHARMACEUTICALS INC (Reporting) CIK: 0001002637 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38085 | Film No.: 191238655
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38085 | Film No.: 191238654
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations